CSIMarket Company Name, Ticker, Competitors, else..
 
Greenwich Lifesciences Inc   (NASDAQ: GLSI)
 

Greenwich Lifesciences Inc's Suppliers Performance

GLSI's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
GLSI Costs vs Sales of Suppliers Growth

• More on GLSI Suppliers






Greenwich Lifesciences Inc's Comment on Supply Chain


The company sources raw materials, active pharmaceutical ingredients (APIs), and finished product candidates for clinical trials and potential commercial supply. It holds an exclusive license agreement with the Henry M. Jackson Foundation (HJF) granting worldwide rights to patents related to GP2 immunotherapy. HJF, a key partner, out-licensed technology from the U.S. military and managed the GP2 Phase IIb clinical trial. HJF also oversaw regulatory filings with the FDA for all four GP2 clinical trials and provided patient and manufacturing data from these trials. The company incorporated FDA correspondences and GP2 data supplied by HJF into its investigational new drug application with the FDA.

Greenwich Lifesciences Inc's Comment on Supply Chain


The company sources raw materials, active pharmaceutical ingredients (APIs), and finished product candidates for clinical trials and potential commercial supply. It holds an exclusive license agreement with the Henry M. Jackson Foundation (HJF) granting worldwide rights to patents related to GP2 immunotherapy. HJF, a key partner, out-licensed technology from the U.S. military and managed the GP2 Phase IIb clinical trial. HJF also oversaw regulatory filings with the FDA for all four GP2 clinical trials and provided patient and manufacturing data from these trials. The company incorporated FDA correspondences and GP2 data supplied by HJF into its investigational new drug application with the FDA.







GLSI's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Greenwich Lifesciences Inc 256.02 0.00 -22.40 4
SUBTOTAL 0.00 0.00 0.00 -


Sources: Greenwich Lifesciences Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Greenwich Lifesciences Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.